Management of acute optic neuritis

被引:181
作者
Hickman, SJ
Dalton, CM
Miller, DH
Plant, GT
机构
[1] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[2] UCL, Inst Neurol, NMR Res Unit, London, England
[3] Moorfields Eye Hosp, Neuroophthalmol Dept, London, England
关键词
D O I
10.1016/S0140-6736(02)11919-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Optic neuritis is a common condition that causes reversible loss of vision. It can be clinically isolated or can arise as one of the manifestations of multiple sclerosis. Occasional cases are due to other causes, and in these instances management can differ radically. The treatment of optic neuritis has been investigated in several trials, the results of which have shown that corticosteroids speed up the recovery of vision without affecting the final visual outcome. Other aspects of management, however, are controversial, and there is uncertainty about when to investigate and when to treat the condition. Here we review the diagnostic features of optic neuritis, its differential diagnosis, and give practical guidance about management of patients. The condition's association with multiple sclerosis will be considered in the light of studies that define the risk for development of multiple sclerosis and with respect to results of trials of disease-modifying drugs in these individuals.
引用
收藏
页码:1953 / 1962
页数:10
相关论文
共 97 条
[41]  
Hauser, 2000, Am J Ophthalmol, V130, P690, DOI 10.1016/S0002-9394(00)00761-3
[42]  
HELMAN SE, 1998, WALSH HOYTS CLIN NEU, P549
[43]   Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis [J].
Holder, GE .
PROGRESS IN RETINAL AND EYE RESEARCH, 2001, 20 (04) :531-561
[44]   Mistaken treatment of anterior ischemic optic neuropathy with interferon β-1a [J].
Horton, JC .
ANNALS OF NEUROLOGY, 2002, 52 (01) :129-129
[45]   Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. [J].
Jacobs, LD ;
Beck, RW ;
Simon, JH ;
Kinkel, RP ;
Brownscheidle, CM ;
Murray, TJ ;
Simonian, NA ;
Slasor, PJ ;
Sandrock, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13) :898-904
[46]   Incidence of optic neuritis in Stockholm, Sweden, 1990-1995 -: II.: Time and space patterns [J].
Jin, YP ;
de Pedro-Cuesta, J ;
Söderström, M ;
Link, H .
ARCHIVES OF NEUROLOGY, 1999, 56 (08) :975-980
[47]   Incidence of optic neuritis in Stockholm, Sweden 1990-1995:: I.: Age, sex, birth and ethnic-group related patterns [J].
Jin, YP ;
de Pedro-Cuesta, J ;
Söderström, M ;
Stawiarz, L ;
Link, H .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 159 (01) :107-114
[48]  
KANSU T, 1989, J CLIN NEURO-OPHTHAL, V9, P277
[49]   Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis [J].
Kapoor, R ;
Miller, DH ;
Jones, SJ ;
Plant, GT ;
Brusa, A ;
Gass, A ;
Hawkins, CP ;
Page, R ;
Wood, NW ;
Compston, DAS ;
Moseley, IF ;
McDonald, WI .
NEUROLOGY, 1998, 50 (01) :230-237
[50]   Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis - Report of the Quality Standards Subcommittee of the American Academy of Neurology [J].
Kaufman, DI ;
Trobe, JD ;
Eggenberger, ER ;
Whitaker, JN .
NEUROLOGY, 2000, 54 (11) :2039-2044